We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
10 Year Est. Return
AUM
$108M
AUM Growth
+$9.72M
Cap. Flow
-$618K
Cap. Flow %
-0.57%
Top 10 Hldgs %
72.13%
Holding
23
New
2
Increased
Reduced
Closed
2

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$10.8M
2
BLDR icon
Builders FirstSource
BLDR
+$7.75M

Top Sells

Rank Stock Value
1
MTN icon
Vail Resorts
MTN
+$11M
2
UNH icon
UnitedHealth
UNH
+$8.12M

Sector Composition

Rank Sector Weight
1 Financials 9.83%
2 Industrials 8.02%
3 Communication Services 6.4%
4 Consumer Discretionary 6.39%
5 Real Estate 4.32%

No holdings matched the selected filter criteria.

Similar funds

Michelson Medical Research Foundation's Q2 2026 Portfolio in Review

As of Q2 2026, Michelson Medical Research Foundation held 23 positions worth $108M, up 9.9% from $98.5M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Michelson Medical Research Foundation's Q2 2026 filing shows 2 new and 2 closed positions. Its largest new stake was CME Group: 39,000 shares worth $8.61M. The largest sale was Vail Resorts, an estimated $11M.

By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 2% a quarter earlier, followed by Industrials and Communication Services.

  • Michelson Medical Research Foundation's largest Q2 2026 buy was CME Group: 39,000 shares worth $8.61M.
  • Michelson Medical Research Foundation fully exited Vail Resorts in Q2 2026, selling an estimated $11M.
  • Michelson Medical Research Foundation's ten largest holdings make up 72% of its $108M portfolio in Q2 2026.
  • Michelson Medical Research Foundation opened 2 new positions and closed 2 in Q2 2026.
  • Michelson Medical Research Foundation's portfolio value rose 9.9% quarter-over-quarter to $108M.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.